OPKO Health, Inc. (OPK)
1.685
+0.02
(+0.90%)
USD |
NASDAQ |
Nov 13, 16:00
1.685
0.00 (0.00%)
After-Hours: 19:59
OPKO Health Enterprise Value : 1.314B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.314B |
| November 11, 2026 | 1.342B |
| November 10, 2026 | 1.342B |
| November 09, 2026 | 1.342B |
| November 06, 2026 | 1.357B |
| November 05, 2026 | 1.371B |
| November 04, 2026 | 1.385B |
| November 03, 2026 | 1.349B |
| November 02, 2026 | 1.349B |
| October 30, 2026 | 1.307B |
| October 29, 2026 | 1.307B |
| October 28, 2026 | 1.278B |
| October 27, 2026 | 1.271B |
| October 26, 2026 | 1.285B |
| October 23, 2026 | 1.285B |
| October 22, 2026 | 1.285B |
| October 21, 2026 | 1.264B |
| October 20, 2026 | 1.307B |
| October 19, 2026 | 1.271B |
| October 16, 2026 | 1.214B |
| October 15, 2026 | 1.271B |
| October 14, 2026 | 1.100B |
| October 13, 2026 | 1.065B |
| October 12, 2026 | 1.108B |
| October 09, 2026 | 1.108B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.100B |
| October 07, 2026 | 1.115B |
| October 06, 2026 | 1.164B |
| October 05, 2026 | 1.243B |
| October 02, 2026 | 1.236B |
| October 01, 2026 | 1.243B |
| September 30, 2026 | 1.271B |
| September 29, 2026 | 1.306B |
| September 28, 2026 | 1.313B |
| September 25, 2026 | 1.321B |
| September 24, 2026 | 1.321B |
| September 23, 2026 | 1.365B |
| September 22, 2026 | 1.388B |
| September 21, 2026 | 1.358B |
| September 18, 2026 | 1.343B |
| September 17, 2026 | 1.306B |
| September 16, 2026 | 1.298B |
| September 15, 2026 | 1.268B |
| September 14, 2026 | 1.261B |
| September 11, 2026 | 1.268B |
| September 10, 2026 | 1.209B |
| September 09, 2026 | 1.246B |
| September 08, 2026 | 1.283B |
| September 04, 2026 | 1.321B |
| September 03, 2026 | 1.298B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Labcorp Holdings, Inc. | 36.76B |
| Quest Diagnostics, Inc. | 34.45B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.445B |
| First Choice Healthcare Solutions, Inc. | 44.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.56M |
| Revenue (Quarterly) | 65.41M |
| Total Expenses (Quarterly) | 100.97M |
| EPS Diluted (Quarterly) | -0.0717 |
| Gross Profit Margin (Quarterly) | 39.14% |
| Profit Margin (Quarterly) | -54.36% |
| Earnings Yield | -11.63% |
| Normalized Earnings Yield | -11.83 |